Moreover, Chen et al. [126] recently found that SFN modulates cytokine storms in patients with COVID-19 by inhibiting the SARS-CoV-2 3CLpro enzyme through a slow-binding, mixed-type mechanism. The gene discussed is SFN; the disease is COVID-19.